CVS Pharmacy Inc. and related entities agreed to pay $315 million to resolve the U.S. Justice Department’s allegations that CVS pharmacies unlawfully filled opioid and other controlled-substance prescriptions and sought reimbursement for many of them from Medicare and other federal health-care programs. The settlement was announced October 13, 2026.
The agreement resolves a civil case, not a court finding that CVS violated the law. The Justice Department says the underlying claims remain allegations, and CVS has said it strongly disagrees with them and admitted no wrongdoing.
As an Amazon Associate I earn from qualifying purchases.
What the $315 million settlement covers
The Justice Department said the alleged conduct occurred from October 17, 2013, through December 2, 2025. Prosecutors invoked the Controlled Substances Act (CSA), which governs lawful dispensing of drugs such as opioids, and the False Claims Act (FCA), which can impose liability when a company seeks federal payment for claims that are legally ineligible for reimbursement.
Recommended Free Tools
| Key term | Details |
|---|---|
| Announced payment | $315 million, announced by the Justice Department on October 13, 2026 |
| Alleged conduct period | October 17, 2013, through December 2, 2025 |
| Government case | Civil complaint filed December 13, 2024, in the U.S. District Court for the District of Rhode Island |
| Statutes cited | Controlled Substances Act and False Claims Act |
| Liability status | No determination of liability; CVS disputes the allegations and the settlement contains no admission of wrongdoing |
| Payment allocation | Not stated in the Justice Department announcement |
The complaint was filed in the case United States ex rel. Hillary Estright v. CVS Health Corporation, et al., No. 22-cv-00222 (D.R.I.). The settlement ends the civil claims described in that case, while the Justice Department’s announcement preserves the distinction between allegations and adjudicated facts.
#1 Best Overall
- Easy to Fill: AUVON AM PM pill organizer 7 day is designed to open on the same side and the lid stays open at 180°, so it is easier and more efficient to fill and retrieve your pills
- Large storage: AUVON weekly pill organizer consists of seven daily pill boxes, each with two compartments for day and night. A single compartment can hold 8 fish oils or 16 capsules. The one single compartment size: 1.5" x 1.7" x 0.8", and the daily pill box size: 3.1" x 1.7" x 0.8"
- High Quality: The shell and inner hinges are reinforced for 10,000 uses. The medication organizer letters were UV printed, which is long-lasting for 10,000 times of use, so you do not need to worry about the rub-off labels
- Portable Designed: Each day of the pill holder can fit in any of your wallet or pockets, and the whole morning and night pill boxes with a black case can protect your medication privacy while holding a week's pills for your travel
- Safe for Use: Made of BPA-free materials that are safe for humans, you can safely store your daily pills in this daily vitamin organizer. Tips: Please put your pills in a dry environment
What prosecutors alleged CVS pharmacies did
Excessive, early and otherwise questionable opioid fills
According to the Justice Department, prosecutors alleged that CVS filled prescriptions for dangerous or excessive opioid quantities and filled opioid prescriptions too early. The allegations concern whether pharmacists should have recognized warning signs and declined, delayed or escalated particular prescriptions under professional and legal requirements.
“Trinity” prescriptions
The complaint also alleged that CVS filled “trinity” combinations. In this context, a trinity prescription combines an opioid, a benzodiazepine and a muscle relaxant—three drug categories that can be abused together and can increase the risk of serious harm. The settlement does not establish that every prescription fitting that description was unlawful; the government alleged that CVS filled combinations lacking a legitimate medical basis in circumstances that should have triggered action.
Rank #2
- 7 DAY PILL ORGANIZER: Weekly Pill sorter helps you to easily plan and distribute your daily doses
- EASY USE: Large Travel compartments, perfect for taking your pill Organizer on the go
- PILL CAPACITY: Holds up to 22 pills per compartment (aspirin-sized)
- BUILT TO LAST: Quality design, built to withstand repeated use
- HEALTHY LIVING: Amazon Basic Care products make living healthier simply easier
Prescriptions linked to alleged pill mills
DOJ further alleged that CVS filled large quantities of controlled-substance prescriptions written by “pill mill” prescribers. The term generally refers to prescribers alleged to issue controlled-substance prescriptions without a legitimate medical purpose. In this case, whether any individual prescription was unlawful remains part of the disputed allegations rather than a finding in a trial verdict.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Alleged workplace and information barriers
The 2024 complaint alleged that corporate performance metrics, incentive compensation and staffing policies made it difficult for pharmacists to meet production expectations while also carrying out required controlled-substance checks. It also alleged that pharmacists were prevented from sharing some warning information about problematic prescribers. The complaint alleged that some prescriptions were billed to federal programs and that, in some instances, patients died after overdosing soon after filling prescriptions the government characterized as unlawful. Those staffing, incentive and patient-harm statements are allegations in the complaint, not established findings.
Rank #3
- Spring Assisted Open Design. We use the latest design on this weekly pill organizer to achieve one-handed operation with the little rubber strips for the smart "lid spring open" feature. The lids are all beautifully colored and marked clearly with the date, everything is clear at a glance so you may find it easy to choose the pills you need. It's quite nice for easy daily dispensing and big enough to hold 8 fish oils or 12 large vitamins for each dose (size of each compartment: 1.3"x1.18"x0.82")
- Say Goodbye to Dumpage Pills. No worries about unwanted dumpage of pills found by pets and kids for your slightest unintentional or incidental touch on the medicine organizer. The push button stays closed once locked and securely snap shut keeping pills safe. It's small and perfectly suitable for travel and is ideal for storing small jewelry or items such as earrings, beads, nail art tips, ect.
- Premium Screen Printing. To avoid screen-printing fonts and icons falling off from the surface of the pill box, we use high-end screen printing ink and strictly do the Ink Adhesion Test with 3M Tapes before shipment. Thus, no need to be frustrated with the missing fonts of "Tuesday" or icons of "PM", and worry about mistakenly taking the wrong tablets.
- BPA-Free Material. This pill case is pretty safe because of being made of food grade materials. You would be worry-free with the BPA-free pill boxes and organizer when storing multiple pill regimes inside. With the transparent plastic lid, it's quite easy to distinguish the pills in each dose without opening the lids.
- What You Receive: 1 x AUVON iMedassist Pill Holder, our 12-month warranty, and friendly customer service.
How the False Claims Act applies to a pharmacy
The False Claims Act can apply when a provider or supplier asks a federal health-care program to pay a claim while failing to meet a legal condition of payment. DOJ alleged that prescriptions unlawfully dispensed under the Controlled Substances Act were then submitted for reimbursement to Medicare and other federal programs. The government’s theory was that those reimbursement requests were false or legally ineligible because the underlying dispensing did not satisfy federal requirements.
The case began as a qui tam action by former CVS employee Hillary Estright. A private whistleblower can file an FCA case on the government’s behalf; the Justice Department may intervene and take over the litigation. DOJ intervened in this matter. The department said the amount of any recovery owed to Estright had not yet been determined, so no whistleblower payment can be inferred from the $315 million figure.
Rank #4
- AM/PM COMPARTMENTS: Plan doses for morning and evening with separate AM/PM compartments
- LARGE CAPACITY: Each compartment can hold 12 aspirin sized tablets
- CONTOURED BOTTOMS: Planner compartments have contoured bottoms so retrieving your medication out of the planner is simple
- CLEAR LIDS: Clear planner lids keep your medication visable to help prevent missed doses
- HEALTHY LIVING: Amazon Basic Care products make living healthier simply easier
What CVS must change under the DEA agreement
Alongside the monetary settlement, CVS entered a memorandum of agreement with the Drug Enforcement Administration. DOJ described the measures as safeguards intended to help ensure controlled substances are dispensed only when medically appropriate.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware match- Reporting hotline: CVS must establish a hotline for employees and members of the public to report suspected illegal dispensing.
- Proactive dispensing monitoring: The company must monitor pharmacy dispensing patterns for warning signs involving controlled substances.
- Prescriber review: CVS must create a process to evaluate prescribers suspected of illegal prescribing.
- Compliance response: The safeguards are intended to help pharmacies identify warning signs and respond to prescriptions that may be unlawful or medically unnecessary.
The announcement does not provide a public dollar-by-dollar breakdown of the $315 million or state that every CVS location will use identical operational procedures beyond the requirements described in the DEA memorandum.
Best Value
- AWARD-WINNING DESIGN: Recipient of the Arthritis Foundation Ease-of-Use Commendation for its effortless, push-button opening—perfect for individuals with arthritis or limited dexterity, making medication management easier and pain-free
- PHARMACIST DESIGNED: Features four silicone “feet” that firmly grip the counter, keeping the planner stable and secure. This thoughtful design allows for easy one-handed opening, making medication management simpler and more convenient
- EXTRA LARGE PILL STORAGE COMPARTMENTS: Each oversized AM/PM section holds up to 35 Aspirin—perfect for organizing large supplements, fish oil, vitamins, and daily medications. Ideal pill organizer for arthritis hands, seniors, and travel use
- CONTOURED SCOOP BOTTOM: The specially designed curved base lets you easily remove pills using just your fingertips, eliminating the need for digging or tipping, making medication access quick and hassle-free
- BUILT TO LAST: Crafted with high-quality BPA-Free materials, this durable design is made to endure repeated use over time without wear, ensuring long-term reliability and consistent performance for your daily medication needs
Timeline of the CVS controlled-substance case
- October 17, 2013: DOJ’s alleged-conduct period begins.
- December 13, 2024: The United States files its civil complaint in Rhode Island after the former employee’s qui tam filing.
- December 2, 2025: DOJ’s alleged-conduct period ends.
- October 13, 2026: DOJ announces the $315 million settlement and the DEA memorandum of agreement.
Did CVS admit wrongdoing, and is the case over?
CVS has publicly said it strongly disagrees with the claims and that the settlement admits no wrongdoing. DOJ likewise states that the settlement resolves allegations and that there has been no determination of liability. In practical terms, the civil action described in the announcement is resolved through the agreement rather than a trial verdict. The company’s continuing obligations are the compliance measures in the DEA memorandum, and the whistleblower’s potential recovery had not yet been determined when DOJ announced the settlement.
Why the settlement matters
The case illustrates how pharmacy conduct can create two related forms of federal exposure: dispensing a controlled substance without the safeguards required by the CSA, and submitting a reimbursement claim to a federal program for that dispensing. It also shows why regulators focus on systems—not only individual prescriptions—including staffing, production targets, escalation channels, prescriber surveillance and ways for employees or the public to report concerns.
For patients, the settlement is not a finding that all opioid prescriptions filled by CVS were improper, nor does the announcement create a general refund program. It addresses the government’s allegations about particular dispensing practices and federal reimbursement claims during the stated period. For taxpayers and federal programs, the payment resolves the government’s civil demand without a public allocation of the settlement amount among Medicare, other programs or individual allegations.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteQuick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
